Insulin doses requirements in patients with type 1 diabetes using glargine U300 or degludec in routine clinical practice

There are not many real-world studies evaluating daily insulin doses requirements (DIDR) in patients with type 1 diabetes (T1D) using second-generation basal insulin analogs, and such comparison is necessary. The aim of this study was to compare DIDR in individuals with T1D using glargine 300 UI/mL...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Investig Med
Asıl Yazarlar: Carral San Laureano, Florentino, Tomé Fernández-Ladreda, Mariana, Jiménez Millán, Ana Isabel, García Calzado, Concepción, Ayala Ortega, María del Carmen
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2021
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8223633/
https://ncbi.nlm.nih.gov/pubmed/33771843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jim-2020-001633
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller